Percheron Therapeutics (ASX:PER) is positioning itself as a small but strategically focused biotechnology company seeking to carve out a role in the rapidly expanding immuno-oncology market. …
Percheron targets next wave of immunotherapy with novel VISTA checkpoint candidate
February 18, 2026 Australian Biotech
Latest Video
Georgia Forrest
New Stories
-
Targeted blood cancer treatments proposed for funding in New Zealand
February 18, 2026 - - Latest News -
Percheron targets next wave of immunotherapy with novel VISTA checkpoint candidate
February 18, 2026 - - Australian Biotech -
Urgent action needed as antibiotic resistance threatens Australia’s health future
February 17, 2026 - - Latest News -
Taylor confirms Anne Ruston will retain health portfolio in opposition reshuffle
February 17, 2026 - - Latest News -
Calls grow for national response to Australia’s worsening medicine shortages
February 17, 2026 - - Latest News -
We do not judge the system on its humanity because we never even discuss it
February 17, 2026 - - Latest News -
PhRMA targets the PBS, urges 'Priority Watch List' inclusion over policy failings
February 17, 2026 - - Latest News